APA (7th ed.) Citation

(2020). Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease.

Chicago Style (17th ed.) Citation

Both Boceprevir and GC376 Efficaciously Inhibit SARS-CoV-2 by Targeting Its Main Protease. 2020.

MLA (8th ed.) Citation

Both Boceprevir and GC376 Efficaciously Inhibit SARS-CoV-2 by Targeting Its Main Protease. 2020.

Warning: These citations may not always be 100% accurate.